Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY-NCChemistry & biodiversity

Molecular Targets and Potential Mechanisms of Luteolin Against Cervical Carcinoma: Integrative Approach Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Validation.

  1. 1School of Life Science, Liaoning University, Shenyang, P.R. China.

Abstract

Cervical carcinoma ranks among the most prevalent malignant neoplasms in gynecology, distinguished by elevated incidence and fatality rates. Therefore, novel treatment strategies are urgently needed. An effective approach for the revelation of natural active components and their molecular mechanisms was provided by network pharmacology, molecular dynamics simulation, and cell biology methods. Olives contain various bioactive components with antioxidant and antitumor activities. Among these, luteolin, as one of the main natural flavonoids, was proven to possess significant antitumor activity. This research identified C-X-C chemokine Ligand 8 (CXCL8) as a significant target linked to the progression of cervical carcinoma, and luteolin was found to have a strong and stable interaction with CXCL8 that significantly downregulated its expression in HeLa cells. Meanwhile, luteolin could significantly suppressed the proliferation, migration, and lipid droplet formation capacity of HeLa cells. These results suggested that luteolin derived from olives could potentially inhibit HeLa cells through the regulation of CXCL8 and offered a theoretical foundation for the utilization of olive-derived bioactive components in the antitumor treatment of cervical carcinoma.

Related

  1. Computational network pharmacology and molecular simulations to explore the potential mechanisms of Pyrrosia piloselloides compounds against prostate cancer.
    Husnul Havid, Ysrafil Ysrafil, Fatmaria Fatmaria +3
    Journal of the Egyptian National Cancer InstitutePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Unraveling the therapeutic mechanisms of placenta hominis for polycystic ovary syndrome through network pharmacology, molecular docking, and experimental validation
    Haixia Pan, Meilin Wu, Ting Mao +7
    Scientific ReportsPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsDOAJ
  3. Berberine and celecoxib synergistically suppress non-small cell lung cancer with EGFR/AKT/COX-2-related signaling: network pharmacology, molecular docking and experimental validation
    Qiang Wang, Chengyu Bian, Xinyuan She +6
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Sensorimotor and Molecular Mechanisms of Non-Contact ACL Injury: An Integrative Hypothesis
    International journal of sports physical therapyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Unraveling the multitarget mechanisms of aloe emodin against periodontitis: a synergy of network pharmacology and experimental validation
    Yifan Zhang, Huijing Ma, Shengxiang Zhang +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMC
BibTeX
@article{pan2026molecular,
  title = {{Molecular Targets and Potential Mechanisms of Luteolin Against Cervical Carcinoma: Integrative Approach Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Validation.}},
  author = {Xinyu Pan and Dan Liu and Junliang Chen and Hanlu Deng and Xiangyu Cao},
  journal = {Chemistry \& biodiversity},
  year = {2026},
  month = oct,
  doi = {10.1002/cbdv.71860},
  url = {https://europepmc.org/article/MED/42904790},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Molecular Targets and Potential Mechanisms of Luteolin Against Cervical Carcinoma: Integrative Approach Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Validation.
AU  - Xinyu Pan
AU  - Dan Liu
AU  - Junliang Chen
AU  - Hanlu Deng
AU  - Xiangyu Cao
PY  - 2026
DA  - 2026/10/01
JO  - Chemistry & biodiversity
DO  - 10.1002/cbdv.71860
UR  - https://europepmc.org/article/MED/42904790
AB  - Cervical carcinoma ranks among the most prevalent malignant neoplasms in gynecology, distinguished by elevated incidence and fatality rates. Therefore, novel treatment strategies are urgently needed. An effective approach for the revelation of natural active components and their molecular mechanisms was provided by network pharmacology, molecular dynamics simulation, and cell biology methods. Olives contain various bioactive components with antioxidant and antitumor activities. Among these, luteolin, as one of the main natural flavonoids, was proven to possess significant antitumor activity. This research identified C-X-C chemokine Ligand 8 (CXCL8) as a significant target linked to the progression of cervical carcinoma, and luteolin was found to have a strong and stable interaction with CXCL8 that significantly downregulated its expression in HeLa cells. Meanwhile, luteolin could significantly suppressed the proliferation, migration, and lipid droplet formation capacity of HeLa cells. These results suggested that luteolin derived from olives could potentially inhibit HeLa cells through the regulation of CXCL8 and offered a theoretical foundation for the utilization of olive-derived bioactive components in the antitumor treatment of cervical carcinoma.
SN  - 1612-1872
SN  - 1612-1880
ER  -